Drug Approval | April 01, 2024
Biocon's European partner Zentiva receives approval from UK MHRA for Liraglutide
The company had earlier announced about the approval received from the MHRA for Liraglutide
The company had earlier announced about the approval received from the MHRA for Liraglutide
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Sen spent a decade with Biocon and held various key roles,
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
These approvals mark significant progress for Venus Remedies in expanding its market presence
Subscribe To Our Newsletter & Stay Updated
